From groceries to baby formula and microchips to cold medicine for children, the supply chain issues that have arisen and grown into crises on President Biden and his administration’s watch are nothing new. But worsening shortages in the supply of drugs used to treat cancers are drawing dire warnings from medical professionals and those who rely on such medical interventions to save lives.
According to the American Society of Health-System Pharmacists, shortages of critical drugs are “the worst they’ve been in a decade” due to “[quality control issues, selected plant closures and other manufacturing woes” that have seen oncology drugs “hit particularly hard in recent months,” Axios reported Tuesday.
“People will die from this shortage, for sure,” came another stark warning from the University of Alabama’s Jonathan McConathy in The Wall Street Journal.
Among the medicines running critically low or being rationed are chemotherapy drug methotrexate, cisplatin, and fluorouracil. Already, Pluvicto — a life-extending drug used in cases of metastatic prostate cancer — has run out and won’t be available to patients for months, Axios added. BCG, used in bladder cancer treatments, was also “being rationed or was not available for use at all.”
via patriottruthnews
